NLRC5 and cancer: The loss of key transcription factors, such as NF-κB and NLRC5, and epigenetic alterations (such as DNA hypermethylation and downregulation of histone deacetylases) can affect the transcription of MHC-I pathway genes, thereby contributing to immune evasion of cancer cells [42].